THERESA BRUNNER

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family DAVIE, FL NPI 1508483702

General Payments — all program years on this page

$751.58

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 26
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $543.81 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $543.8120

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $326.8914
Galderma Laboratories, L.P. $216.926

By program year

Program yearAmountRecords
2022 $136.532
2023 $71.244
2024 $543.8120

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1106839927 ABBVIE INC. $69.55 05/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106839929 ABBVIE INC. $24.08 05/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106839931 ABBVIE INC. $53.00 05/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106839933 ABBVIE INC. $4.28 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106839935 ABBVIE INC. $9.92 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106839937 ABBVIE INC. $3.57 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106839939 ABBVIE INC. $10.39 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106839941 ABBVIE INC. $2.62 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106839943 ABBVIE INC. $2.24 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106839945 ABBVIE INC. $10.58 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106839947 ABBVIE INC. $3.31 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106839949 ABBVIE INC. $125.00 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106839951 ABBVIE INC. $3.50 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106839953 ABBVIE INC. $4.85 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145346189 Galderma Laboratories, L.P. $14.14 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145346191 Galderma Laboratories, L.P. $14.69 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145346193 Galderma Laboratories, L.P. $14.79 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145346195 Galderma Laboratories, L.P. $14.72 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145346197 Galderma Laboratories, L.P. $150.25 11/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145346199 Galderma Laboratories, L.P. $8.33 12/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.